Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector
News May 24, 2006
ChipInspector is designed to enable biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays.
It employs a proprietary single probe approach based on latest genomic annotation from Genomatix' ElDorado annotation pipeline.
Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.
"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector," states Dr. Martin Seifert, VP Microarray business and collaborative research.
"We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer."
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE